Hennion & Walsh Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-78,233	Closed	-$3.08M	–	852
2023 Q2	$3.08M	Sell	78,233 -713	-0.9%	-$25.2K	0.18%	143
2023 Q1	$1.92M	Buy	78,946 +3,406	+5%	+$74.6K	0.12%	212
2022 Q4	$1.62M	Buy	75,540 +30,718	+69%	+$656K	0.1%	240
2022 Q3	$804K	Buy	44,822 +11,160	+33%	+$146K	0.05%	381
2022 Q2	$324K	Buy	+33,662	New	+$423K	0.02%	608

Hennion & Walsh Asset Management's ISEE Position: Q3 2023 in Review

Hennion & Walsh Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 78,233 shares — an estimated $3.08M sold.

Hennion & Walsh Asset Management first reported a position in ISEE in Q2 2022 and held it in 5 quarters. The position peaked at $3.08M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Hennion & Walsh Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Hennion & Walsh Asset Management sold 78,233 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.08M.
Hennion & Walsh Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Hennion & Walsh Asset Management's IVERIC bio, Inc. Common Stock position peaked at $3.08M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.